# Narval CC Mandibular Repositioning Device in the Second-line Treatment of Severe Obstructive Sleep Apnea Hypopnea (OSAH)

> **NCT01326143** · — · COMPLETED · sponsor: **ResMed** · enrollment: 360 (actual)

## Conditions studied

- Obstructive Sleep Apnea Syndrome

## Interventions

- **DEVICE:** ORM Narval MRD

## Key facts

- **NCT ID:** NCT01326143
- **Lead sponsor:** ResMed
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2019-02
- **Final completion:** 2019-02-27
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2020-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01326143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01326143, "Narval CC Mandibular Repositioning Device in the Second-line Treatment of Severe Obstructive Sleep Apnea Hypopnea (OSAH)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01326143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*